[go: up one dir, main page]

DE69207863D1 - Vorrichtung zur kontrollierten Wirkstoffreigabe - Google Patents

Vorrichtung zur kontrollierten Wirkstoffreigabe

Info

Publication number
DE69207863D1
DE69207863D1 DE69207863T DE69207863T DE69207863D1 DE 69207863 D1 DE69207863 D1 DE 69207863D1 DE 69207863 T DE69207863 T DE 69207863T DE 69207863 T DE69207863 T DE 69207863T DE 69207863 D1 DE69207863 D1 DE 69207863D1
Authority
DE
Germany
Prior art keywords
active substance
core
aperture
exposed
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69207863T
Other languages
English (en)
Other versions
DE69207863T2 (de
Inventor
Sham Kumar Chopra
Avinash Kumar Nangia
David Lee
Thomas Patrick Molloy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Inc
Original Assignee
Glaxo Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919124106A external-priority patent/GB9124106D0/en
Priority claimed from GB919124108A external-priority patent/GB9124108D0/en
Priority claimed from GB929205463A external-priority patent/GB9205463D0/en
Application filed by Glaxo Canada Inc filed Critical Glaxo Canada Inc
Publication of DE69207863D1 publication Critical patent/DE69207863D1/de
Application granted granted Critical
Publication of DE69207863T2 publication Critical patent/DE69207863T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Molding Of Porous Articles (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Container, Conveyance, Adherence, Positioning, Of Wafer (AREA)
  • Seal Device For Vehicle (AREA)
DE69207863T 1991-11-13 1992-11-10 Vorrichtung zur kontrollierten Wirkstoffreigabe Expired - Lifetime DE69207863T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919124106A GB9124106D0 (en) 1991-11-13 1991-11-13 Device
GB919124108A GB9124108D0 (en) 1991-11-13 1991-11-13 Device
GB929205463A GB9205463D0 (en) 1992-03-12 1992-03-12 Device

Publications (2)

Publication Number Publication Date
DE69207863D1 true DE69207863D1 (de) 1996-03-07
DE69207863T2 DE69207863T2 (de) 1996-06-05

Family

ID=27265924

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69207863T Expired - Lifetime DE69207863T2 (de) 1991-11-13 1992-11-10 Vorrichtung zur kontrollierten Wirkstoffreigabe

Country Status (15)

Country Link
US (1) US5342627A (de)
EP (1) EP0542364B1 (de)
JP (2) JP3768247B2 (de)
AT (1) ATE133331T1 (de)
AU (1) AU658942B2 (de)
CA (1) CA2082740C (de)
CZ (1) CZ337392A3 (de)
DE (1) DE69207863T2 (de)
DK (1) DK0542364T3 (de)
ES (1) ES2083074T3 (de)
GR (1) GR3019431T3 (de)
IL (1) IL103723A0 (de)
NO (1) NO924372L (de)
NZ (1) NZ245100A (de)
TW (1) TW262387B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5398850A (en) 1993-08-06 1995-03-21 River Medical, Inc. Gas delivery apparatus for infusion
DE4341442C2 (de) * 1993-12-04 1998-11-05 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoffen sowie ihre Verwendung
DE4431653C2 (de) 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5700245A (en) 1995-07-13 1997-12-23 Winfield Medical Apparatus for the generation of gas pressure for controlled fluid delivery
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
US6110500A (en) * 1998-03-25 2000-08-29 Temple University Coated tablet with long term parabolic and zero-order release kinetics
EP1095650A1 (de) * 1999-10-29 2001-05-02 Universiteit Leiden Zweiphasensystem mit kontrollierter Freigabe
US6569152B2 (en) 2000-03-21 2003-05-27 Farrington Pharmaceuticals, Llc Sustained release delivery systems for solutes
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
DE60139087D1 (de) * 2000-12-14 2009-08-06 Ortho Mcneil Janssen Pharm Verfahren zu Herstellung von Zubereitungen enthaltend einen Steroidhormon und ein Stabilisierungsmittel in nicht-kristallinen Form
US6960357B2 (en) 2001-05-25 2005-11-01 Mistral Pharma Inc. Chemical delivery device
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
IL162000A0 (en) * 2001-11-14 2005-11-20 Alza Corp Injectable depot compositions and use thereof
WO2003041757A2 (en) 2001-11-14 2003-05-22 Alza Corporation Catheter injectable depot compositions and uses thereof
USD481456S1 (en) 2002-01-30 2003-10-28 Smithkline Beecham P.L.C. Capsule
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US7125563B2 (en) * 2002-04-12 2006-10-24 Dava Pharmaceuticals, Inc. Sustained release pharmaceutical preparations and methods for producing the same
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
US8637512B2 (en) * 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
AR040709A1 (es) * 2002-07-29 2005-04-13 Glaxo Group Ltd Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion
EP2030611A1 (de) * 2002-07-31 2009-03-04 Alza Corporation Injizierbare multimodale Polymerablagerungszusammensetzungen und Verwendungen damit
ATE392886T1 (de) * 2002-07-31 2008-05-15 Alza Corp Injizierbare depotzusammensetzungen und deren verwendung
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
GB0400452D0 (en) * 2004-01-09 2004-02-11 Norton Healthcare Ltd A pharmaceutical composition
US20050163847A1 (en) * 2004-01-21 2005-07-28 Andrx Pharmaceuticals, Llc Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug
GB0403628D0 (en) * 2004-02-18 2004-03-24 Arrow Group Ltd Compression-coated tablets and the manufacture thereof
EP1781264B1 (de) 2004-08-04 2013-07-24 Evonik Corporation Verfahren zur herstellung von abgabevorrichtungen und damit erhaltene vorrichtungen
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
DE602006018529D1 (de) * 2005-12-29 2011-01-05 Osmotica Kereskedelmi Es Szolgaltato Kft Mehrschichtige tablette mit dreifacher freisetzungskombination
US8691272B2 (en) * 2005-12-30 2014-04-08 Intelgenx Corp. Multilayer tablet
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
EP2222281B1 (de) 2007-12-20 2018-12-05 Evonik Corporation Verfahren zur herstellung von mikropartikeln mit geringer restlösemittelmenge
US20110142905A1 (en) * 2008-08-14 2011-06-16 Bioneer A/S Coated tablets with remaining degradation surface over the time
WO2010096820A1 (en) * 2009-02-23 2010-08-26 Eurand, Inc. Controlled release compositions comprising anti-cholinergic drugs
US20110136815A1 (en) * 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
US10610528B2 (en) 2009-12-08 2020-04-07 Intelgenx Corp. Solid oral film dosage forms and methods for making same
SG183993A1 (en) * 2010-03-09 2012-10-30 Alkermes Pharma Ireland Ltd Alcohol resistant enteric pharmaceutical compositions
US9233076B2 (en) 2010-12-13 2016-01-12 Purdue Pharma L.P. Controlled release dosage forms
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2015160595A1 (en) * 2014-04-14 2015-10-22 Abbott Molecular, Inc. Medium used for blood sample collection and transport
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US12163326B1 (en) * 2019-10-01 2024-12-10 NeverClog, LLC System for capturing and destroying hair or waste within a commercial shower drain
JP2023515918A (ja) 2020-01-13 2023-04-17 デュレクト コーポレーション 不純物が低減された徐放性薬物送達システム及び関連の方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US480076A (en) * 1892-08-02 Thomas p
US3113076A (en) * 1956-07-03 1963-12-03 Henry R Jacobs Medicinal tablets
GB1022171A (en) * 1961-06-15 1966-03-09 Wellcome Found Prolonged release oral pharmaceutical tablets and their manufacture
US3851648A (en) * 1973-10-11 1974-12-03 Mead Johnson & Co Zero-order release device
US4816262A (en) * 1986-08-28 1989-03-28 Universite De Montreal Controlled release tablet
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance

Also Published As

Publication number Publication date
EP0542364A1 (de) 1993-05-19
DK0542364T3 (da) 1996-03-11
NO924372L (no) 1993-05-14
JP3768247B2 (ja) 2006-04-19
JP2004189754A (ja) 2004-07-08
NO924372D0 (no) 1992-11-12
NZ245100A (en) 1995-06-27
TW262387B (de) 1995-11-11
JP4166716B2 (ja) 2008-10-15
JPH05262640A (ja) 1993-10-12
GR3019431T3 (en) 1996-06-30
CA2082740C (en) 2003-10-14
IL103723A0 (en) 1993-04-04
US5342627A (en) 1994-08-30
EP0542364B1 (de) 1996-01-24
AU2827292A (en) 1993-05-20
DE69207863T2 (de) 1996-06-05
AU658942B2 (en) 1995-05-04
ES2083074T3 (es) 1996-04-01
CA2082740A1 (en) 1993-05-14
ATE133331T1 (de) 1996-02-15
CZ337392A3 (en) 1993-10-13

Similar Documents

Publication Publication Date Title
DE69207863D1 (de) Vorrichtung zur kontrollierten Wirkstoffreigabe
DK0436370T3 (da) Farmaceutisk præparat til kontrolleret afgivelse og fremgangsmåde til fremstilling deraf
FR2622799B1 (fr) Forme de dosage pharmaceutique a liberation controlee et procede pour sa preparation
ITMI922617A1 (it) Forme matriciali multistrato per il rilascio controllato di principi attivi
DK156289A (da) Farmaceutisk praeparat indrettet til kontrolleret afgivelse af aktiv bestanddel
DE68905850D1 (de) Zusammensetzung zur beschichtung der aussenoberflaeche von sportbaellen und so erhaltene baelle.
ES2049414T3 (es) Dispositivo de administracion.
DE3773468D1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
PT1287822E (pt) Composicoes farmaceuticas orais de libertacao controlada de mesalazina
NO915043D0 (no) Osmoseanordning for kontrollert avgivelse av et nyttig middel
ITMI911880A1 (it) Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
NO894467D0 (no) Reservoar for styrt frigjoering av aktive substanser, anordning som inneholder den, fremgangsmaate for aa fremstille den, og bruk av anordningen.
MY106930A (en) Controlled release device
ATE212543T1 (de) Pharmazeutische zusammensetzung aus stabilisierten lipophilen matrizen mit kontrollierter wirkstofffreisetzung
RU92004402A (ru) Устройство для регулируемого выделения активного вещества и способ его изготовления
ATE75394T1 (de) Orales osmotisches system fuer metoprolol mit verbesserten formulierungseigenschaften.
TH16921A (th) อุปกรณ์การปลดปล่อยชนิดควบคุม
IT1279650B1 (it) Impianto per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
IT8222430A0 (it) Forme farmaceutiche a lento rilascio di principi attivi a elevata idrosolubilita'.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R071 Expiry of right

Ref document number: 542364

Country of ref document: EP